APA (7th ed.) Citation

Iaffaldano, P., Lucisano, G., Guerra, T., Paolicelli, D., Portaccio, E., Inglese, M., . . . Spitaleri, D. (2024). A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis. Annals of Clinical & Translational Neurology, 11(8), 2008. https://doi.org/10.1002/acn3.52118

Chicago Style (17th ed.) Citation

Iaffaldano, Pietro, et al. "A Comparison of Natalizumab and Ocrelizumab on Disease Progression in Multiple Sclerosis." Annals of Clinical & Translational Neurology 11, no. 8 (2024): 2008. https://doi.org/10.1002/acn3.52118.

MLA (9th ed.) Citation

Iaffaldano, Pietro, et al. "A Comparison of Natalizumab and Ocrelizumab on Disease Progression in Multiple Sclerosis." Annals of Clinical & Translational Neurology, vol. 11, no. 8, 2024, p. 2008, https://doi.org/10.1002/acn3.52118.